Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€108.60

€108.60

1.110%
1.2
1.110%
€172.32
 
04.07.25 / Tradegate WKN: 870980 / Symbol: RGEN / Name: Repligen Corp / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Repligen Corp. Stock

There is an upward development for Repligen Corp. compared to yesterday, with an increase of €1.20 (1.110%).
With 15 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 172 € there is a hugely positive potential of 58.38% for Repligen Corp. compared to the current price of 108.6 €.
So far the community has only identified positive things for Repligen Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Repligen Corp. in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Repligen Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Repligen Corp. 1.110% 2.841% -3.552% -2.949% -22.401% -31.801% -3.894%
Opko Health Inc. -4.000% 0.037% -7.137% -1.401% -22.995% -58.071% -66.808%
Amicus Therapeutics Inc. 3.000% 6.846% 0.000% -42.458% -43.716% -51.036% -62.681%
Indivior plc 2.310% 8.333% 7.438% -6.475% 9.244% -28.137% 138.751%

Comments

Prediction Buy
Perf. (%) 1.73%
Target price 129.405
Change
Ends at 24.06.26

Repligen Corporation (NASDAQ: RGEN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $150.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat
Show more

Repligen Corporation (NASDAQ: RGEN) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for RGEN provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -12.84%
Target price 158.796
Change
Ends at 05.05.26

Repligen Co. (NASDAQ: RGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $180.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat
Show more